Reuters logo
BRIEF-‍Moody's says pace of drug price increases slows, though possible change to 340B program would hurt NFP hospital margins​
September 27, 2017 / 2:29 PM / in 22 days

BRIEF-‍Moody's says pace of drug price increases slows, though possible change to 340B program would hurt NFP hospital margins​

Sept 27 (Reuters) - Moody‘s:

* ‍Moody’s says pace of drug price increases slows, though possible change to 340B program would hurt NFP hospital margins​

* ‍Moody’s says proposed reduction of Medicare Part B outpatient drug reimbursement to 340B hospitals would represent headwind for hospitals already facing pressure​

* ‍Moody’s says if changes were implemented to 340B, largest impact would be on pharmaceutical companies with product mix weighted towards biotech drugs​

* ‍Moody’s on pace of drug price says on generic drug side, expect some of the pressure will ease as U.S. FDA approves more generic drugs for first time Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below